Physician Wealth Advisors’s Preformed Line Products PLPC Stock Holding History

Physician Wealth Advisors’s Portfolio PLPC Stock Details PLPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411	Buy	+1	New	+$350	﹤0.01%	2217

Other funds holding PLPC

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Physician Wealth Advisors's PLPC Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Preformed Line Products (PLPC) in Q2 2026: 1 share worth $411. The stake represents ﹤0.01% of the portfolio and ranks #2217 among its holdings.

207 funds tracked by Wall St. Rank hold PLPC as of Q2 2026.

Physician Wealth Advisors held 1 share of Preformed Line Products worth $411 as of Q2 2026.
Preformed Line Products was a new Physician Wealth Advisors position in Q2 2026.
Preformed Line Products made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2217 holding.
207 funds tracked by Wall St. Rank held Preformed Line Products as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.